Back to Search
Start Over
Repeated olanzapine treatment mitigates PTSD like symptoms in rats with changes in cell signaling factors.
- Source :
-
Brain Research Bulletin . Jun2018, Vol. 140, p365-377. 13p. - Publication Year :
- 2018
-
Abstract
- Post Traumatic Stress Disorder is an anxiety disorder with prolonged distortion of rational behavior. In this study, we report the preclinical potential of olanzapine (OLZ) in the treatment of PTSD. Since the atypical antipsychotics have modulating effects on cell protective and destructive factors, we tested the effects of OLZ in PTSD regarding these cell modulating factors. Rats, when subjected to stress-restress (SRS) model of PTSD, showed a derangement in cell protective factors like the decline in BDNF, ERK, and CREB. While the adversarial factors like caspase-3 were enhanced. Four weeks treatment with OLZ at doses of 1 and 10 mg/kg significantly mitigated the SRS-induced derangement related to PTSD. OLZ at doses of 1 and 10 mg/kg enhanced BDNF, ERK and CREB levels which were reduced by SRS in PTSD animals. Further, at the fore mentioned doses it also inhibited the elevation of caspase-3 a downstream apoptotic factor. Besides, OLZ also showed mitigation in behavioral alterations related to anxiety and memory brought about by PTSD. These effects of OLZ were comparable to that of paroxetine a clinically approved drug for PTSD in terms of biochemical and behavioral assessments indicating its anti-PTSD potential. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 03619230
- Volume :
- 140
- Database :
- Academic Search Index
- Journal :
- Brain Research Bulletin
- Publication Type :
- Academic Journal
- Accession number :
- 130625556
- Full Text :
- https://doi.org/10.1016/j.brainresbull.2018.06.003